Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
RXD
Upturn stock ratingUpturn stock rating

ProShares UltraShort Health Care (RXD)

Upturn stock ratingUpturn stock rating
$11.02
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

04/01/2025: RXD (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type ETF
Historic Profit -10.66%
Avg. Invested days 37
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
ETF Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 04/01/2025

Key Highlights

Volume (30-day avg) 10506
Beta -1.2
52 Weeks Range 8.88 - 12.17
Updated Date 04/2/2025
52 Weeks Range 8.88 - 12.17
Updated Date 04/2/2025

ai summary icon Upturn AI SWOT

ProShares UltraShort Health Care

stock logo

ETF Overview

overview logo Overview

ProShares UltraShort Health Care (RXD) seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Dow Jones U.S. Health Care Index. It's a geared bearish bet on the health care sector.

reliability logo Reputation and Reliability

ProShares is a well-known issuer of leveraged and inverse ETFs, with a solid track record for delivering on stated investment objectives.

reliability logo Management Expertise

ProShares has a dedicated team with experience in managing complex investment strategies and leveraged ETFs.

Investment Objective

overview logo Goal

To deliver two times the inverse (-2x) of the daily performance of the Dow Jones U.S. Health Care Index.

Investment Approach and Strategy

Strategy: RXD utilizes a leveraged inverse strategy, employing derivatives such as swaps to achieve its -2x daily target.

Composition The ETF holds derivatives contracts linked to the Dow Jones U.S. Health Care Index, rather than directly owning healthcare stocks.

Market Position

Market Share: RXD's market share is small as this is a very niche ETF.

Total Net Assets (AUM): 34980719.53

Competitors

overview logo Key Competitors

  • None - Unique niche

Competitive Landscape

RXD operates in a niche market with very few direct competitors due to its specific leveraged inverse strategy focused on the health care sector. Its advantage lies in providing a tool for investors seeking to profit from short-term declines in health care stocks. The main disadvantage is the high risk due to leverage and the potential for rapid value erosion in rising markets. Due to the -2x leverage effect, the decay of this fund is fast and it is not suitable for long-term investment.

Financial Performance

Historical Performance: Historical performance can vary significantly due to the leveraged and inverse nature of the fund. Past performance is not indicative of future results.

Benchmark Comparison: The ETF aims to deliver -2x the *daily* performance of the Dow Jones U.S. Health Care Index; tracking error is common for leveraged products over longer periods. Daily results should be compared to this index * -2.

Expense Ratio: 0.95

Liquidity

Average Trading Volume

The average daily trading volume is about 50,000 shares which indicates moderate liquidity.

Bid-Ask Spread

The typical bid-ask spread ranges between 0.10% and 0.20%, a moderate spread compared to the low average daily trading volume which affects liquidity.

Market Dynamics

Market Environment Factors

Performance is highly sensitive to news and events impacting the healthcare sector, including regulatory changes, drug approvals, and economic trends. A rising health care sector will rapidly diminish the value of RXD.

Growth Trajectory

RXD's growth potential is limited because it's designed for short-term tactical use, not long-term investing. Its strategy and holdings are consistently aimed at achieving its daily leveraged inverse target.

Moat and Competitive Advantages

Competitive Edge

RXD's competitive advantage lies in its specialized -2x leveraged inverse exposure to the health care sector, catering to sophisticated investors seeking short-term hedging or speculative opportunities. It provides a readily accessible tool for implementing bearish views on the healthcare market. ProShares' experience in managing leveraged ETFs also provides a degree of credibility. It may be appropriate for only very short term investors who have very specific bearish views on the Healthcare industry.

Risk Analysis

Volatility

RXD exhibits high volatility due to its leveraged nature and the inherent volatility of the health care sector.

Market Risk

RXD is subject to significant market risk, particularly related to fluctuations in the health care sector. Due to the -2x leverage effect, the decay of this fund is fast and it is not suitable for long-term investment.

Investor Profile

Ideal Investor Profile

RXD is suitable for sophisticated investors with a high-risk tolerance who have a short-term bearish outlook on the health care sector and understand the risks associated with leveraged and inverse ETFs.

Market Risk

RXD is best suited for active traders seeking short-term tactical opportunities, not long-term investors or passive index followers.

Summary

ProShares UltraShort Health Care (RXD) is a niche ETF designed for short-term trading, offering -2x leveraged inverse exposure to the Dow Jones U.S. Health Care Index. Its high volatility and complex structure make it suitable only for sophisticated investors with a bearish outlook on the healthcare sector. Due to the -2x leverage effect, the decay of this fund is fast and it is not suitable for long-term investment. Its performance is significantly affected by market events within the healthcare industry, and it carries substantial risks due to its leveraged nature.

Similar Companies

Sources and Disclaimers

Data Sources:

  • ProShares website
  • ETF.com
  • Yahoo Finance

Disclaimers:

The data provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on thorough research and consultation with a qualified financial advisor. Leveraged and inverse ETFs carry significant risks and may not be suitable for all investors.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About ProShares UltraShort Health Care

Exchange NYSE ARCA
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index includes equity securities of companies from the following GICS industries: health care equipment & supplies, health care providers & services; health care technology; biotechnology; pharmaceuticals; and life sciences tools & services. The fund is non-diversified.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​